PM
BSX icon

Pembroke Management’s Boston Scientific BSX Stock Holding History

Pembroke Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,736
Closed -$234K – 101
2026
Q1 		$234K Sell
3,736
-464
-11% -$37.1K 0.03% 93
2025
Q4 		$400K Sell
4,200
-130
-3% -$12.7K 0.04% 81
2025
Q3 		$423K Buy
4,330
+368
+9% +$38.1K 0.04% 74
2025
Q2 		$426K Buy
+3,962
New +$401K 0.05% 62

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pembroke Management's BSX Position: Q2 2026 in Review

Pembroke Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,736 shares — an estimated $234K sold.

Pembroke Management first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $426K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pembroke Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Pembroke Management sold 3,736 Boston Scientific shares in Q2 2026, an estimated $234K.
  • Pembroke Management first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Pembroke Management's Boston Scientific position peaked at $426K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pembroke Management's 13F filing for Q2 2026, filed 22 Jul 2026.